NCT00126919已完成4 期
Randomized Crossover Trial of Sonication Followed by 5 Minute LMX4 Application Compared With 30 Minute LMX4 Application for Topical Anesthesia Prior to Subcutaneous Port Access in Children
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 40
- 试验地点
- 2
- 主要终点
- pain
研究概览
简要总结
Children ages 3-17 who are undergoing port access receive both standard care, topical medicine for numbing (LMX4), and the study intervention which utilizes ultrasound to speed the onset of LMX4 from 30 minutes to 5 minutes. The procedures will be performed on 2 separate visits to the clinic. The child's pain with the access procedure is evaluated.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 3 Years 至 17 Years（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Children ages 3-17 with subcutaneous port
排除标准
- •Emergent need for port access
- •Allergy to lidocaine sodium lauryl sulfate
结局指标
主要结局
pain
次要结局
- safety-skin effects
- tolerability
研究者
William Zempsky, MD
Director, Pain Relief Program
Connecticut Children's Medical Center
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Safety and Effectiveness of Sonu for Pediatric Nasal CongestionNasal Congestion and InflammationsNCT06773013Third Wave Therapeutics31
已完成
3 期
Normal Saline Flushes at 12 vs 24 Hours Intervals for Maintaining Peripheral Intravenous Catheters PatencyPainNCT02221024IRCCS Burlo Garofolo400
已完成
不适用
L. Reuteri ATCC PTA 5289 & L. Reuteri DSM 17938 for the Treatment of Children With Pharyngitis and/or TonsillitisTonsillitisPharyngitisNCT03377374Innovacion y Desarrollo de Estrategias en Salud70
已完成
3 期
Phase 3 Study to Compare the Efficacy and Safety of AR01 to a Placebo Solution for Relief of Pain in Acute Otitis MediaAcute Otitis MediaNCT02044341Arbor Pharmaceuticals, Inc.304
终止
3 期
Study to Compare Efficacy and Safety of AR01 to a Placebo Solution for Relief of Pain in Acute Otitis Media (AR01007)Acute Otitis MediaNCT02074007Arbor Pharmaceuticals, Inc.178